Medicare Enrolled
Dr. Maged Amine, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amine? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amine
Dr. Maged Amine is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Amine performed 4,260 Medicare services across 3,031 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amine received a total of $40,747 from 54 pharmaceutical and/or device companies across 668 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amine is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 22% volume in TX$ $40,747 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,260
Medicare services
Top 22% in TX for cardiovascular disease
3,031
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~213 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 863 | $91 | $314 |
| EKG interpretation and report | 680 | $6 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test | 456 | $43 | $212 |
| Electrocardiogram (EKG), 12-lead | 443 | $10 | $126 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 268 | $25 | $35 |
| Echocardiogram, transthoracic | 266 | $141 | $1,461 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 169 | $50 | $406 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 150 | $351 | $3,509 |
| New patient office visit (45-59 min) | 142 | $118 | $483 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 96 | $21 | $120 |
| Remote pacemaker monitoring, 90 days | 73 | $22 | $149 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 67 | $144 | $1,028 |
| Initial hospital admission, moderate complexity | 62 | $102 | $401 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $10 | $64 |
| Ultrasound of both sides of head and neck blood flow | 42 | $147 | $1,003 |
| Cardiac catheterization | 40 | $189 | $1,310 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 39 | $16 | $111 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 37 | $1,450 | $11,970 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 37 | $20 | $104 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 36 | $41 | $175 |
| Office visit, established patient (20-29 min) | 35 | $59 | $212 |
| Ultrasound study of arm and leg arteries | 23 | $55 | $484 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 20 | $10 | $63 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 20 | $19 | $102 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $97 | $680 |
| Coronary stent placement | 18 | $461 | $2,405 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $10 | $66 |
| Hospital follow-up visit, high complexity | 17 | $96 | $302 |
| Ultrasound of heart, follow-up | 16 | $66 | $451 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $2 | $252 |
| Evaluation of cardiac rhythm monitor system | 15 | $36 | $168 |
| Insertion of heart rhythm monitor under skin | 11 | $3,523 | $26,634 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $85 | $472 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.5% high complexity
23.6% medium
65.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$40,747
Total received (2018-2024)
Avg $5,821/year across 7 years
Top 12% in TX for cardiovascular disease
54
Companies
668
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,680 (72.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,931 (24.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,135 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,674
2023$5,463
2022$4,418
2021$1,824
2020$879
2019$6,533
2018$16,955
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$8,744
Medtronic Vascular, Inc.
$7,508
Novartis Pharmaceuticals Corporation
$6,284
Chiesi USA, Inc.
$4,381
ABIOMED
$1,873
Impulse Dynamics (USA) Inc.
$1,502
ARALEZ PHARMACEUTICALS US INC.
$1,125
Boston Scientific Corporation
$865
Biosense Webster, Inc.
$862
Amgen Inc.
$826
Bard Peripheral Vascular, Inc.
$479
Janssen Pharmaceuticals, Inc
$463
BARD PERIPHERAL VASCULAR, INC.
$430
Actelion Pharmaceuticals US, Inc.
$354
Medtronic, Inc.
$344
PFIZER INC.
$340
Boehringer Ingelheim Pharmaceuticals, Inc.
$306
Medtronic USA, Inc.
$279
Amarin Pharma Inc.
$277
HeartFlow, Inc.
$264
Baxter Healthcare
$248
Merck Sharp & Dohme LLC
$248
Esperion Therapeutics, Inc.
$237
Tactile Systems Technology Inc
$230
Lexicon Pharmaceuticals, Inc.
$219
E.R. Squibb & Sons, L.L.C.
$209
SANOFI-AVENTIS U.S. LLC
$207
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$169
HEARTFLOW, INC.
$164
AstraZeneca Pharmaceuticals LP
$159
BIOTRONIK INC.
$157
AngioDynamics, Inc.
$113
iRhythm Technologies, Inc.
$102
ARBOR PHARMACEUTICALS, INC.
$98
CARDIVA MEDICAL, INC.
$92
Novo Nordisk Inc
$90
Merck Sharp & Dohme Corporation
$67
Astellas Pharma US Inc
$64
Kiniksa Pharmaceuticals, Ltd.
$59
BOSTON SCIENTIFIC CORPORATION
$40
Gilead Sciences, Inc.
$38
Relypsa, Inc.
$31
Aziyo Biologics, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$26
Inspire Medical Systems, Inc.
$25
Azurity Pharmaceuticals, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$16
GE HEALTHCARE
$14
Cook Medical LLC
$14
Dilon Technologies, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$12
AltaThera Pharmaceuticals LLC
$11
Itamar Medical Inc
$10
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 55.3% of total payments
Associated products mentioned in payments ›
AMVIA EDGE · AQUAMANTYS · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Arcalyst · Assurity Pacemaker · BIOMONITOR · BRILINTA · BodyGuardian · CAMZYOS · CARDENE · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · COBALT DR MRI SURESCAN · CONFIRM RX · CROSSER · CardioMEMS HF System · Carnation Ambulatory Monitor · Carto 3 System · Carto Smarttouch · Claria MRI · ClosureRFS · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DxTerity · ECM · EDARBI · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · Edarbi · Edarbyclor · Ellipse ICD · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · Fortify Assura · GALLANT · General - Therapies · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INSPIRE · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LIFESTENT · LINQ II · LUTONIX · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Miami Instruments Joseph Lamelas Knot Pusher · Mitra Clip system · MyCareLink Smart · NEXLETOL · NEXLIZET · OPSUMIT · OPTIMIZER · OPTIS · Optimizer · Ozempic · PRALUENT · PRESSUREWIRE · Percepta · PlasmaBlade · Quadra Allure MP RF CRT Pacemkr · Quartet CRT Lead · RESONATE EL ICD VR · Repatha · Resolute · Reveal LINQ · Rivacor 7 DR-T · SELECTSITE · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRUEVIEW · ULTRASCORE · UPTRAVI · VASCUTRAK · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Venclose Maven Catheter · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO · XIENCE V · ZILVER PTX · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $956 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
382
Per 100K population
8.0
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Amine is a clinical cardiology specialist, with above-average Medicare volume (top 22% in TX), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Amine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amine performed 863 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amine receive payments from pharmaceutical companies?
Yes. Dr. Amine received a total of $40,747 from 54 companies across 668 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amine's costs compare to other cardiovascular diseases in Houston?
Dr. Amine's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology